Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Breast Cancer Res. 2024 Jun 3;26(1):90. doi: 10.1186/s13058-024-01840-7.
Nottingham histological grade (NHG) is a well established prognostic factor in breast cancer histopathology but has a high inter-assessor variability with many tumours being classified as intermediate grade, NHG2. Here, we evaluate if DeepGrade, a previously developed model for risk stratification of resected tumour specimens, could be applied to risk-stratify tumour biopsy specimens.
A total of 11,955,755 tiles from 1169 whole slide images of preoperative biopsies from 896 patients diagnosed with breast cancer in Stockholm, Sweden, were included. DeepGrade, a deep convolutional neural network model, was applied for the prediction of low- and high-risk tumours. It was evaluated against clinically assigned grades NHG1 and NHG3 on the biopsy specimen but also against the grades assigned to the corresponding resection specimen using area under the operating curve (AUC). The prognostic value of the DeepGrade model in the biopsy setting was evaluated using time-to-event analysis.
Based on preoperative biopsy images, the DeepGrade model predicted resected tumour cases of clinical grades NHG1 and NHG3 with an AUC of 0.908 (95% CI: 0.88; 0.93). Furthermore, out of the 432 resected clinically-assigned NHG2 tumours, 281 (65%) were classified as DeepGrade-low and 151 (35%) as DeepGrade-high. Using a multivariable Cox proportional hazards model the hazard ratio between DeepGrade low- and high-risk groups was estimated as 2.01 (95% CI: 1.06; 3.79).
DeepGrade provided prediction of tumour grades NHG1 and NHG3 on the resection specimen using only the biopsy specimen. The results demonstrate that the DeepGrade model can provide decision support to identify high-risk tumours based on preoperative biopsies, thus improving early treatment decisions.
诺丁汉组织学分级(NHG)是乳腺癌组织病理学中一个成熟的预后因素,但评估者之间存在高度的变异性,许多肿瘤被归类为中间分级,即 NHG2 级。在这里,我们评估了之前开发的用于切除肿瘤标本风险分层的 DeepGrade 模型是否可应用于肿瘤活检标本的风险分层。
共纳入来自瑞典斯德哥尔摩 896 例乳腺癌患者的 1169 张全切片图像中的 11955755 个瓦片。应用深度卷积神经网络模型 DeepGrade 预测低风险和高风险肿瘤。它在活检标本上与临床分配的 NHG1 和 NHG3 分级进行了评估,同时还与使用曲线下面积(AUC)的对应切除标本分级进行了评估。在活检环境中,使用生存时间分析评估了 DeepGrade 模型的预后价值。
基于术前活检图像,DeepGrade 模型预测切除肿瘤的临床分级 NHG1 和 NHG3 的 AUC 为 0.908(95%CI:0.88;0.93)。此外,在 432 例临床分配的 NHG2 肿瘤中,281 例(65%)被归类为 DeepGrade-低危,151 例(35%)为 DeepGrade-高危。使用多变量 Cox 比例风险模型,估计 DeepGrade 低危和高危组之间的风险比为 2.01(95%CI:1.06;3.79)。
仅使用活检标本,DeepGrade 即可预测切除标本的肿瘤分级 NHG1 和 NHG3。结果表明,DeepGrade 模型可提供基于术前活检的高危肿瘤识别决策支持,从而改善早期治疗决策。